Microsoft partners with Eagle Genomics to address challenges related to immune disorders

Microbiome is the ecosystem of good bacteria, fungi and viruses present in living organisms. It plays a key role in defending against diseases. Due to anti-bacterial products, pesticides and antibiotics, there is a widespread microbial imbalance leading to several issues such as immune disorders, mental health problems and antibiotic resistance. Microsoft Genomics is partnering with Eagle Genomics to address these issues.

Eagle Genomics’ knowledge discovery platform will use Azure and ML to transform data into actionable insights that drive scientific decision making. Enterprises in food processing industry can use the Eagle Genomics’ platform to assess a product’s suitability for retail / consumption.

The e[automateddatascientist] platform is already deployed in global companies including Unilever and GSK; Eagle’s collaboration with Microsoft will enable the solution to be easily scaled at the enterprise level across these customers, and many more.

Geralyn Miller, Director of Microsoft Genomics added: “This collaboration with Eagle Genomics presents exciting opportunities to gain meaningful insight from microbiome data, an area of research that, when better understood, promises to have a significant impact on our health and wellbeing. This is in line with Microsoft’s mission to bring the power and scale of the cloud to precision-medicine, spanning the productization of core services and fundamental research.”

Learn more about this partnership in the link below.

Source: Eagle Genomics 

Some links in the article may not be viewable as you are using an AdBlocker. Please add us to your whitelist to enable the website to function properly.